These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 25504164)
1. [Cardiac magnetic resonance and uremic cardiomyopathy]. Di Lullo L; Gorini A; Rivera R; De Pascalis A; Bellasi A; Russo D; Barbera V; Ronco C; Balducci A; Santoboni A G Ital Nefrol; 2014; 31(6):. PubMed ID: 25504164 [TBL] [Abstract][Full Text] [Related]
2. Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance. Edwards NC; Moody WE; Chue CD; Ferro CJ; Townend JN; Steeds RP JACC Cardiovasc Imaging; 2014 Jul; 7(7):703-14. PubMed ID: 25034920 [TBL] [Abstract][Full Text] [Related]
3. A comprehensive characterization of myocardial and vascular phenotype in pediatric chronic kidney disease using cardiovascular magnetic resonance imaging. Cheang MH; Barber NJ; Khushnood A; Hauser JA; Kowalik GT; Steeden JA; Quail MA; Tullus K; Hothi D; Muthurangu V J Cardiovasc Magn Reson; 2018 Mar; 20(1):24. PubMed ID: 29609642 [TBL] [Abstract][Full Text] [Related]
4. Is uremic cardiomyopathy a direct consequence of chronic kidney disease? Chinnappa S; Hothi SS; Tan LB Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):127-30. PubMed ID: 24404903 [TBL] [Abstract][Full Text] [Related]
5. Diffuse Myocardial Interstitial Fibrosis and Dysfunction in Early Chronic Kidney Disease. Hayer MK; Price AM; Liu B; Baig S; Ferro CJ; Townend JN; Steeds RP; Edwards NC Am J Cardiol; 2018 Mar; 121(5):656-660. PubMed ID: 29366457 [TBL] [Abstract][Full Text] [Related]
6. [Erythrocyte abnormalities and their possible role in cardiovascular complications of uremia]. Bonomini M; Arduini A; Sirolli V; Di Pietro N; Pandolfi A G Ital Nefrol; 2017; 34(1):. PubMed ID: 28177098 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association. Zoccali C; Mallamaci F; Adamczak M; de Oliveira RB; Massy ZA; Sarafidis P; Agarwal R; Mark PB; Kotanko P; Ferro CJ; Wanner C; Burnier M; Vanholder R; Wiecek A Cardiovasc Res; 2023 Sep; 119(11):2017-2032. PubMed ID: 37249051 [TBL] [Abstract][Full Text] [Related]
8. [Imaging in CKD]. Ratti C; Grassi L; Ferramosca E; Raggi P G Ital Nefrol; 2017 Mar; 34(Suppl 69):205-222. PubMed ID: 28682040 [TBL] [Abstract][Full Text] [Related]
9. Altered relative concentrations of high-energy phosphates in patients with uraemic cardiomyopathy measured by magnetic resonance spectroscopy. Patel RK; Mark PB; Macnaught G; Stevens KK; McQuarrie EP; Steedman T; Gillis K; Dargie HJ; Jardine AG Nephrol Dial Transplant; 2012 Jun; 27(6):2446-51. PubMed ID: 22241795 [TBL] [Abstract][Full Text] [Related]
10. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome. Lekawanvijit S Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30200452 [TBL] [Abstract][Full Text] [Related]
11. Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease. Bansal N Semin Nephrol; 2017 Mar; 37(2):120-131. PubMed ID: 28410646 [TBL] [Abstract][Full Text] [Related]
12. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657 [TBL] [Abstract][Full Text] [Related]